Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Correction to "Impact of liquid sublingual immunotherapy on asthma onset and progression in patients with allergic rhinitis: a nationwide population-based study (EfficAPSI study)" [The Lancet Regional Health - Europe 41 (2024) 100915].
Demoly P, Molimard M, Bergmann JF, Delaisi B, Gouverneur A, Vadel J, Collin C, Girard L, Scurati S, Devillier P. Demoly P, et al. Among authors: gouverneur a. Lancet Reg Health Eur. 2024 Oct 22;46:101120. doi: 10.1016/j.lanepe.2024.101120. eCollection 2024 Nov. Lancet Reg Health Eur. 2024. PMID: 39498359 Free PMC article.
Impact of liquid sublingual immunotherapy on asthma onset and progression in patients with allergic rhinitis: a nationwide population-based study (EfficAPSI study).
Demoly P, Molimard M, Bergmann JF, Delaisi B, Gouverneur A, Vadel J, Collin C, Girard L, Scurati S, Devillier P. Demoly P, et al. Among authors: gouverneur a. Lancet Reg Health Eur. 2024 Apr 26;41:100915. doi: 10.1016/j.lanepe.2024.100915. eCollection 2024 Jun. Lancet Reg Health Eur. 2024. PMID: 38707866 Free PMC article.
A successful linkage of a named patient products of sublingual immunotherapy-dispensing registry to French healthcare insurance database (SNDS): methodological constitution of the EfficAPSI cohort.
Devillier P, Molimard M, Bergmann JF, Delaisi B, Gouverneur A, Vadel J, Collin C, Girard L, Scurati S, Demoly P. Devillier P, et al. Among authors: gouverneur a. Expert Rev Clin Immunol. 2024 Apr;20(4):405-412. doi: 10.1080/1744666X.2023.2294040. Epub 2023 Dec 19. Expert Rev Clin Immunol. 2024. PMID: 38112340 Free article.
GLP-1 Receptor Agonists and the Risk of Thyroid Cancer.
Bezin J, Gouverneur A, Pénichon M, Mathieu C, Garrel R, Hillaire-Buys D, Pariente A, Faillie JL. Bezin J, et al. Among authors: gouverneur a. Diabetes Care. 2023 Feb 1;46(2):384-390. doi: 10.2337/dc22-1148. Diabetes Care. 2023. PMID: 36356111
Clinical impact of STK11 mutation in advanced-stage non-small cell lung cancer.
Rosellini P, Amintas S, Caumont C, Veillon R, Galland-Girodet S, Cuguillière A, Nguyen L, Domblides C, Gouverneur A, Merlio JP, Bezin J, Girodet PO. Rosellini P, et al. Among authors: gouverneur a. Eur J Cancer. 2022 Sep;172:85-95. doi: 10.1016/j.ejca.2022.05.026. Epub 2022 Jun 24. Eur J Cancer. 2022. PMID: 35759814
31 results